p48/64 MW HPC in Aneurysm Occlusion (PIANO): Prospective, Multicenter, Single-arm Clinical Trial to Determine Safety and Effectiveness of the Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms.

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

To determine safety and effectiveness of the p48 MW HPC and p64 MW HPC flow diverter in the treatment of wide-necked intracranial aneurysms.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Subject is ≥ 18 years

• Subject has a mRS ≤2 before the index procedure

• Subject has an unruptured or recanalized intracranial aneurysm (IA). The subject may also have a previous ruptured aneurysm, provided rupture of this aneurysm has occurred more than 30 days from the index procedure. The IA must have the following characteristics below:

‣ Saccular or fusiform morphology

⁃ Located in the internal carotid artery and its branches

⁃ Aneurysm neck ≥4 mm or dome-to-neck ratio \<2

⁃ Parent vessel diameter ≥2.0mm and ≤5.0mm both distal and proximal to the target IA

• Subject or subject's legally authorized representative (LAR) has provided written informed consent and has agreed to comply with study procedures.

Locations
United States
New York
UBNS
RECRUITING
Buffalo
Contact Information
Primary
Mairead Cleary
mairead.cleary@wallabyphenox.com
+35391740100
Backup
Nguyet T Labenski
nguyet.labenski@wallabyphenox.com
Time Frame
Start Date: 2025-12
Estimated Completion Date: 2032-05
Participants
Target number of participants: 214
Treatments
Experimental: Intervention/Treatment
Device: Flow diversion using the p48 MW HPC Device: Flow diversion using the p64 MW HPC
Related Therapeutic Areas
Sponsors
Collaborators: Phenox GmbH
Leads: phenox Inc.

This content was sourced from clinicaltrials.gov